Your browser doesn't support javascript.
loading
A prospective Phase II study to examine the relationship between quality of life and adverse events of first-line chemotherapy plus cetuximab in patients with KRAS wild-type unresectable metastatic colorectal cancer: QUACK trial.
Iwamoto, Shigeyoshi; Ooki, Akira; Morita, Satoshi; Hara, Hiroki; Tanioka, Hiroaki; Satake, Hironaga; Kataoka, Masato; Kotaka, Masahito; Kagawa, Yoshinori; Nakamura, Masato; Shingai, Tatsushi; Ishikawa, Masashi; Miyake, Yasuhiro; Sudo, Takeshi; Hashiguchi, Yojiro; Yabuno, Taichi; Sakamoto, Junichi; Tsuji, Akihito; Ando, Masahiko; Yamaguchi, Kensei.
Afiliación
  • Iwamoto S; Cancer Center, Aichi Medical University, Nagakute, Japan.
  • Ooki A; Department of Gastroenterology, Saitama Cancer Center, Saitama, Japan.
  • Morita S; Department of Gastroenterological Chemotherapy, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Hara H; Department of Biomedical Statistics and Bioinformatics, Kyoto University, Kyoto, Japan.
  • Tanioka H; Department of Gastroenterology, Saitama Cancer Center, Saitama, Japan.
  • Satake H; Department of Medical Oncology, Okayama Rosai Hospital, Okayama, Japan.
  • Kataoka M; Department of Medical Oncology, Kobe City Medical Center General Hospital, Kobe, Japan.
  • Kotaka M; Department of Surgery, National Hospital Organization Nagoya Medical Center, Nagoya, Japan.
  • Kagawa Y; Gastrointestinal Cancer Center, Sano Hospital, Kobe, Japan.
  • Nakamura M; Department of Surgery, Kansai Rosai Hospital, Amagasaki, Japan.
  • Shingai T; Comprehensive Cancer Center, Aizawa Hospital, Matsumoto, Japan.
  • Ishikawa M; Department of Surgery, Osaka Saiseikai Senri Hospital, Suita, Japan.
  • Miyake Y; Department of Surgery, Shikoku Central Hospital, Shikokuchuo, Japan.
  • Sudo T; Department of Surgery, Osaka Minato Central Hospital, Osaka, Japan.
  • Hashiguchi Y; Department of Surgery, Yamagata Prefectural Central Hospital, Yamagata, Japan.
  • Yabuno T; Department of Surgery, Teikyo University School of Medicine, Tokyo, Japan.
  • Sakamoto J; Department of Surgery, Yokohama Municipal Citizen's Hospital, Yokohama, Japan.
  • Tsuji A; Tokai Central Hospital, Kakamigahara, Japan.
  • Ando M; Department of Medical Oncology, Kagawa University, Takamatsu, Japan.
  • Yamaguchi K; Center for Advanced Medicine and Clinical Research, Nagoya University, Nagoya, Japan.
Cancer Med ; 7(9): 4217-4227, 2018 09.
Article en En | MEDLINE | ID: mdl-30051609
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Calidad de Vida / Neoplasias Colorrectales / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudio: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cancer Med Año: 2018 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Calidad de Vida / Neoplasias Colorrectales / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudio: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cancer Med Año: 2018 Tipo del documento: Article